Clinical Trial Update: Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion

View source ↗

Summary

A clinical study is evaluating outcomes of prothrombin complex concentrate (PCC) versus recombinant activated factor VIIa for trauma-associated massive transfus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia
• Thromboembolism
• Trauma

Drugs mentioned

• NovoSeven RT (Recombinant activated factor VII)
• Prothrombin Complex Concentrate (four-factor PCC) (Prothrombin complex concentrate, four-factor)

Snippet

Sponsor: Zeliha Alicikus | Conditions: Thromboembolus, Massive Blood Transfusion; Thrombocytopenia | Status: RECRUITING